1. Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8⁺ cytotoxic T lymphocytes

   • Elke S. Bergmann-Leitner
   • Scott I. Abrams

   Original Article Pages: 445 - 455

2. Purified hybrid cells from dendritic cell and tumor cell fusions are superior activators of antitumor immunity

   • J. Li
   • L. Holmes
   • Y. Wei

   Original Article Pages: 456 - 462

3. Dendritic cells pulsed with tumor extract–cationic liposome complex increase the induction of cytotoxic T lymphocytes in mouse brain tumor

   • Hideo Aoki
   • Masaaki Mizuno
   • Jun Yoshida

   Original Article Pages: 463 - 468

4. A TGFβRII frameshift-mutation-derived CTL epitope recognised by HLA-A2-restricted CD8⁺ T cells

   • Ingvil Sæterdal
   • Marianne K. Gjertsen
   • Gustav Gaudernack

   Original Article Pages: 469 - 476

5. Biodistribution of ¹¹¹indium-labeled macrophages infused intravenously in patients with renal carcinoma

   • Véronique Quillien
   • Annick Moisan
   • Louis Toujas

   Original Article Pages: 477 - 482

6. Soluble ICAM-1 in breast cancer: clinical significance and biological implications

   • Wolfgang J. Köstler
   • Sandra Tomek
   • Christoph C. Zielinski

   Original Article Pages: 483 - 490

7. Nitric oxide synthase inhibitor and IL-18 enhance the anti-tumor immune response of rats carrying an intrahepatic colon carcinoma

   • Pontus Hegardt
   • Bengt Widegren
   • Hans Sjögren

   Original Article Pages: 491 - 501